| Feedback |  |
Drugs & Medications > Tarceva > User Reviews
User Reviews for Tarceva
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Tarceva.
Filter by condition:
Condition   |
Reviews | Compare | Avg. Ratings |
|
|---|---|---|---|---|
| Non-Small Cell Lung Cancer | 2 review(s) | 21 medications |
 |
6.7 |
| Pancreatic Cancer | 0 review(s) | 16 medications | Not rated - Be the first | |
Renal Cell Carcinoma |
0 review(s) | 19 medications | Not rated - Be the first | |
Sort by: Reviews for Tarceva
| Anonymous user said: |  | User Rating: |
|
9.0 |
||
Tarceva (erlotinib) for Non-Small Cell Lung Cancer: My mother started taking Tarceva after being diagnosed with stage 4 lung cancer. So far she is doing okay - very chilled and developed a rash on her face which they say is not uncommon. Took her off of it for a few days to clear up the rash and hopefully she can continue. Her cancer travelled to her brain so we had a few more set backs but they tell us Tarceva has been known to help the brain in some cases just praying for the best.
|
||||||
| March 9, 2009 5:46 PM | ||||||
| Anonymous user said: | | User Rating: |
|
10 |
||
Tarceva (erlotinib) for Non-Small Cell Lung Cancer: Mom was diagnosed with lung cancer in 2003 and went through treatment. In 2004 developed metastatic bone cancer in her back which was non treatable by chemo or radiation. Her doctor put her on Tarceva in 2005 and did a PET scan base line. We repeated the PET scan in Jan 2009 and her cancer has not progressed AT ALL! There are even a couple spots in her back that showed cancer in 2005 that did not appear in her 2009 PET scan. Mom has had no side effects from this medication. The doctors in 2005 thought Mom would only live 6 months, I am extreamly pleased to have her for 4 years and still counting.
|
||||||
| February 6, 2009 2:03 PM | ||||||
